Mark Plavsic
2021
In 2021, Mark Plavsic earned a total compensation of $8.4M as Chief Technology Officer at Fate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $92,055 |
|---|---|
| Option Awards | $993,361 |
| Salary | $230,137 |
| Stock Awards | $6,915,474 |
| Other | $148,000 |
| Total | $8,379,027 |
Plavsic received $6.9M in stock awards, accounting for 83% of the total pay in 2021.
Plavsic also received $92.1K in non-equity incentive plan, $993.4K in option awards, $230.1K in salary and $148K in other compensation.
Rankings
In 2021, Mark Plavsic's compensation ranked 1,357th out of 12,406 executives tracked by ExecPay. In other words, Plavsic earned more than 89.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,357 out of 12,406 | 89th |
Division Manufacturing | 486 out of 5,494 | 91st |
Major group Chemicals And Allied Products | 177 out of 2,369 | 93rd |
Industry group Drugs | 148 out of 2,090 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 43 out of 452 | 91st |
Source: SEC filing on April 25, 2022.
Plavsic's colleagues
We found five more compensation records of executives who worked with Mark Plavsic at Fate Therapeutics in 2021.
2021
J Wolchko
Fate Therapeutics
Chief Executive Officer
2021
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
2021
Cindy Tahl
Fate Therapeutics
General Counsel
2021
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
2021
Edward Dulac
Fate Therapeutics